RHYTHM CO.,LTD. FY2027 Q1 Earnings Report

Financial Highlights

• Net Sales: ¥9.02B
• Operating Income: ¥564M
• Net Income: ¥376M
• EPS: ¥47.29

Income Statement

Balance Sheet

Profitability Ratios

Year-over-Year Comparison

Share Information

Segment Information

Full Year Forecast

---

AI Financial Analysis

Executive Summary

FY2027 Q1 was mixed: topline growth and solid operating execution in PrecisionProducts were offset by weak DailyCommodities, higher non-operating drags, and the absence of last year’s large extraordinary gain, resulting in a sharp YoY decline in bottom-line. Revenue rose 7.5% YoY to 90.15bn JPY, while operating income declined 4.2% YoY to 5.64bn JPY, and ordinary income fell 14.7% YoY to 6.29bn JPY. Net income dropped to 3.76bn JPY (-75.1% YoY), with EPS of 47.29 JPY. Gross margin contracted 184 bps to 22.5% (from ~24.3%), mainly on DailyCommodities underperformance and FX headwinds. Operating margin compressed 78 bps to 6.3% (from ~7.0%). Ordinary margin contracted 183 bps to ~7.0% (from ~8.8%), as FX losses of 0.95bn JPY partially offset higher dividend and interest income. Net margin fell 1,380 bps to 4.2% (from ~18.0%) due primarily to the absence of last year’s extraordinary gain (7.59bn JPY) and normalization of tax expense (effective tax rate 35.0%). Earnings quality was affected by a 0.50bn JPY impairment in DailyCommodities and FX losses equal to ~17% of operating profit. Working capital intensity remains elevated, with flagged DSO of 200 days, DIO of 425 days, and a CCC of 485 days, indicating cash conversion pressure. Balance sheet strength is high (current ratio 404.7%, quick ratio 289.5%, interest coverage 25.64x), providing resilience while management addresses segment mix and inventory efficiency. Segment mix shifted decisively toward PrecisionProducts (78.6% of sales; margin 11.1%), while DailyCommodities posted a loss (-9.9% margin). Investment securities increased 26.5% YoY to 74.95bn JPY, lifting comprehensive income to 16.97bn JPY via valuation gains. Retained earnings declined 14.6% YoY to 57.48bn JPY, reflecting prior shareholder returns and weaker bottom-line. Against full-year guidance, Q1 sales and profit progression is broadly on track to ahead for sales/OP/ordinary, while net income progress (22%) is slightly below a linear pace due to one-offs. The quarter underscores the core profitability of PrecisionProducts, the need to remediate DailyCommodities, and the urgency to normalize working capital. With conservative leverage (D/E 0.46x; Debt/Capital 6.5%) and abundant liquidity, the company has capacity to execute operational improvements. Forward focus should be on inventory normalization, FX risk management, and restoring profitability in DailyCommodities to sustain OPM recovery and ROE.

Profitability Analysis

ROE decomposed (DuPont 3-factor): Net Profit Margin (4.2%) × Asset Turnover (0.180) × Financial Leverage (1.46x) = ~1.1% ROE. The largest YoY delta is in the net profit margin, which fell from an atypically high level last year (boosted by 7.59bn JPY extraordinary income) to 4.2% this quarter. Business drivers include: strong PrecisionProducts mix and margin (11.1%) partially offset by DailyCommodities loss (-9.9%), FX losses of 0.95bn JPY, and a normalized tax burden (35%). This change is not structural at the operating level; rather, it reflects the absence of non-recurring gains and transitory FX headwinds—hence partly reversible if segment mix improves and FX stabilizes. Operating leverage was modestly negative as SG&A grew slightly while gross margin compressed; operating margin contracted 78 bps despite 7.5% sales growth, indicating cost pressure in DailyCommodities and currency effects. Watch for any trend where SG&A growth outpaces revenue; in Q1, SG&A was 14.66bn JPY versus 14.50bn JPY YoY, well-contained, placing the onus on gross margin recovery.

Growth Assessment

Revenue grew 7.5% YoY to 90.15bn JPY, driven by PrecisionProducts (+26.7% YoY) offsetting a steep decline in DailyCommodities (-30.1% YoY). Operating income declined 4.2% YoY to 5.64bn JPY as gross margin compression more than offset volume scale benefits. Ordinary income fell 14.7% YoY due to higher non-operating expenses (notably FX losses). Net income decreased 75.1% YoY due to the absence of last year’s one-time gains and higher effective taxes. PrecisionProducts’ 11.1% OPM and 120% YoY OI growth underpin core growth sustainability, contingent on stable demand and FX. DailyCommodities remains a drag with a segment loss and an impairment charge, necessitating portfolio/price/cost actions. Comprehensive income improved to 16.97bn JPY on valuation gains in investment securities, but this is non-cash and market-dependent. Outlook depends on normalizing DailyCommodities losses, recapturing gross margin through pricing and mix, and managing FX exposure.

Financial Health

Liquidity is strong with a current ratio of 404.7% and a quick ratio of 289.5%. Leverage is conservative: D/E at 0.46x and Debt/Capital at 6.5%, supported by interest coverage of 25.64x. Working capital is sizable (215.25bn JPY), with inventories at 81.34bn JPY and receivables at 49.42bn JPY, comfortably exceeding short-term obligations (current liabilities 70.65bn JPY), implying low maturity mismatch risk. Investment securities stand at 74.95bn JPY (15.0% of assets), enhancing financial flexibility but introducing market valuation sensitivity into equity and comprehensive income. Retained earnings of 57.48bn JPY provide loss-absorption capacity. No off-balance sheet obligations were noted in disclosures provided.

Notable B/S Changes

Investment Securities: +15.7bn JPY (+26.5%) - Higher market valuations; boosts comprehensive income but raises equity market sensitivity. Retained Earnings: -9.1bn JPY (-14.6%) - Reflects prior shareholder returns and weaker bottom-line; moderates internal capital buffer.

Cash Flow Quality

Profit conversion to cash is pressured by flagged working capital metrics: DSO of 200 days, DIO of 425 days, and a CCC of 485 days signal slow collection and elevated inventory holdings. Such a profile typically dampens operating cash flow and can necessitate incremental working capital financing if demand slows. FX losses below ordinary income also indicate non-operating volatility affecting cash predictability. Free cash flow headroom for dividends will hinge on inventory normalization and receivables collection in coming quarters. No clear signs of working capital window-dressing appear in the provided data, but the magnitude of inventories warrants close monitoring for obsolescence and markdown risk.

Dividend Sustainability

Full-year guidance implies EPS of 211.72 JPY and DPS of 167.6 JPY, a payout ratio of approximately 79%, which is elevated but potentially sustainable if operating targets are met and working capital normalizes. Balance sheet strength (high liquidity, low leverage) supports dividend capacity near term. However, sensitivity to FX and segment mix, plus the current working capital drag, reduces cushion if earnings underperform. Monitoring FCF generation relative to dividend commitments through FY progress will be critical.

Risk Assessment

Business risks include Segment concentration: PrecisionProducts contributes 78.6% of revenue, heightening exposure to its demand cycles, DailyCommodities structural weakness: -9.9% margin and an impairment charge indicate ongoing profitability challenges, FX volatility: 0.95bn JPY FX losses in Q1 materially impacted ordinary income, Inventory obsolescence/markdown risk given high DIO (425 days).

Financial risks include Cash conversion risk: CCC of 485 days elevates reliance on working capital and may constrain OCF, Market valuation risk from investment securities (74.95bn JPY; 15% of assets) influencing equity and comprehensive income, Tax burden normalization (35% ETR) lowers net profit sensitivity versus prior year’s unusually low taxes.

Key concerns include ROIC at 1.5% is below a 5% threshold, signaling suboptimal capital efficiency, Gross margin compression (−184 bps YoY) amid FX headwinds and loss-making DailyCommodities, Earnings volatility from non-recurring items: prior-year extraordinary gains vs. current-year impairment.

Investment Implications

Key takeaways include Core engine intact: PrecisionProducts grew 26.7% YoY with 11.1% OPM and 120% OI growth, Headline NI weakness driven by one-offs: last year’s large extraordinary gain not repeated; this year includes impairment, Working capital intensity and FX losses weighed on ordinary income and cash quality, Balance sheet remains a strength, providing runway to fix DailyCommodities and de-risk inventories, Guidance tracking: Q1 progress on sales/OP/ordinary is on or ahead of linear pace; NI slightly behind.

Metrics to watch include Segment OPM: PrecisionProducts margin durability and DailyCommodities loss reduction, Gross margin trajectory vs. FX and pricing, Inventory levels and DIO; CCC improvement quarter-over-quarter, Ordinary income sensitivity to FX gains/losses, Progress to full-year NI and payout coverage.

Regarding relative positioning, Versus domestic precision component manufacturers, Rhythm combines a solid core segment with a weaker consumer-facing business, resulting in lower consolidated ROE/ROIC and heavier working capital. Liquidity and leverage are better-than-peers on average, but inventory efficiency lags, making execution on supply chain and product mix crucial for re-rating.